Life has a strange sense of timing.
Two days ago, I was told that ENDOless would not be pitching on a small local stage.
The reason, more or less, was that the audience would not be interested. That we were not the right fit. That we were not prepared enough. That maybe women’s health, chronic pain, endometriosis, research equity, and real-world data were not the priorities in that room.
And today, I get to announce that ENDOless has been selected as one of the Top 10 startups for RAISE the STAKES 2026, the startup competition of RAISE Summit, one of the biggest AI events in Europe.
Out of more than 1,500 applicants, ENDOless will pitch at the Carrousel du Louvre.
I am proud.
Not in the polished, corporate, “happy to share” way.
I am proud in the deeply human way.
Proud because this journey is not clean.
Proud because building a startup from lived experience is not romantic most days.
Proud because being a woman founder, an immigrant, a patient, and someone trying to build in health, AI, research, and infrastructure at the same time is not exactly the easiest configuration in the founder starter pack.
And yet, here we are.
ENDOless was not born because I saw a “market opportunity” in women’s health.
It was born because I lived the problem.
I lived the pain.
I lived the diagnostic delay.
I lived the dismissal.
I lived the mental load of managing a chronic condition while trying to have a career, a life, ambition, love, dignity, and some form of stability.
And the more I listened to other women, the clearer it became: this was never only my story.
It is a systemic data problem.
Women with chronic pain generate information every day: symptoms, flares, triggers, treatment responses, behaviour patterns, hormonal changes, sleep disruption, fatigue, work impact, and emotional load.
But most of this information disappears.
It is not captured properly.
It is not structured.
It is not connected to research.
It is not used to improve care.
It is not visible enough to influence prevention, clinical decisions, pharma research, or public health.
So yes, ENDOless is about women’s health.
But it is also about infrastructure.
It is about transforming lived experience into structured, research-grade real-world evidence.
It is about helping women understand and manage their health while generating the kind of data that researchers, clinicians, pharma, and healthcare systems desperately need.
It is about making chronic pain measurable, visible, and finally actionable.
Yet, still, sometimes, we hear that it is niche. Half of the population is not a niche.
That women’s health is not a priority. It has been treated that way. That does not make it true.
That chronic pain is too specific. Pain shapes everything: work, relationships, mental health, healthcare use, and quality of life.
That endometriosis is too narrow.
That the market is complicated. Of course it is. The whole system is involved: patients, doctors, researchers, pharma, employers, insurers, and public health.
That research takes time. Then let’s stop wasting years because the right data was never collected.
That healthcare is hard. Yes. That is not an argument against building. It is the reason to build better.
All of this is true.
But “hard” is not the same as “not important”.
And “underfunded” is not the same as “small”.
Women’s health has been treated as a niche for too long, while half of the population continues to carry symptoms, delays, costs, and invisible work that our systems have failed to measure properly.
This is exactly why ENDOless exists.
So today, I am allowing myself to feel proud.
Proud of ENDOless.
Proud of the team.
Proud of every woman who trusted us with her story.
Proud of every mentor, partner, friend, investor, researcher, and supporter who did not dismiss the problem because it was complex.
Proud of the fact that even when one door closes, another one can open onto a much bigger stage.
There is something almost absurd and very beautiful in the contrast.
Two days ago: “This audience may not be interested.”
Today: “You are pitching at one of Europe’s biggest AI events.”
Life turns quickly.
But the mission stays the same.
Make women’s pain visible.
Make research possible.
Make better care inevitable.
See you at the Carrousel du Louvre.
xoxo
